• Thu, March 6, 2025

by: Money

Scared of Stock Market Swings? Don't Cash Out

by: MoneyWeek

Can European stock markets continue their rally?

The national stock markets that are most commonly tracked include Germany's DAX and France's CAC. Their major indices are the DAX 40 and CAC-40, which track the forty largest stocks in each respective country.

by: Barchart

Is Arista Networks Stock Outperforming the Nasdaq?

With a market cap of $110.8 billion, Arista Networks Inc (ANET) provides cloud networking solutions for data centers, AI, and enterprise environments, offering high-performance Ethernet switches and routers optimized for next-generation networks with multiple silicon architectures.

by: WOPRAI

Short squeeze is starting in shares of LHX at $212.28, after crossing above the $212.227 Trigger Price

by: MarketWatch

'I'm deeply disturbed': My portfolio lost 20%. With Trump's trade war, do I sell my stocks and buy gold?

With the current state of domestic and global affairs, I'm at a loss as to how to keep my economic stability in check."

by: AOL

Should you tap your home equity to invest?

Older homeowners — those of the Gen X and baby boomer generations — were less sanguine about using home equity to invest. Only 13% and 8%, respectively, thought it a good idea, the Home Equity Insights Survey found.

by: Insider

Sorry American firms, the AI trade has moved to China

Chinese tech stocks are rising sharply on new AI announcements.Alibaba announced a new AI model that it claims is more efficient than DeepSeek.Meanwhile, top-performing US-based AI stocks like Nvidia are struggling.

by: Bankrate

5 sure-fire signs of a stock market bubble

What is a stock market bubble? A stock market bubble is a speculative frenzy when stock prices vastly exceed the fundamental value of the companies underlying them. A market as a

by: TipRanks

Coca-Cola Europacific Partners price target raised to $98 from $92 at Barclays

Barclays analyst Lauren Lieberman raised the firm's price target on Coca-Cola Europacific Partners (CCEP) to $98 from $92 and keeps an Overweight

by: Investopedia

S&P 500 Gains and Losses Today: AI Stocks Fall After Soft Outlook From Marvell Technology

The S&P 500 dropped 1.8% on Thursday, March 6, 2025, as investors reacted to the back-and-forth around U.S. trade policies and awaited Friday's jobs report.

by: MSN

Potbelly (NASDAQ:PBPB) Reports Q4 In Line With Expectations But Stock Drops

Casual sandwich chain Potbelly (NASDAQ:PBPB) in Q4 CY2024, but sales fell by 7.3% year on year to $116.6 million. Its non-GAAP profit of $0.13 per share was 92.6% above analysts' consensus estimates.

by: CNN

US stocks slide and Nasdaq enters correction as chaos over Trump's tariffs intensifies

The rocky week on Wall Street continued on Thursday as investors grappled with further uncertainty from President Donald Trump's tariffs.

by: Mint

Stocks to buy today: Ankush Bajaj recommends three stocks for 7 March

The Nifty 50 surged 0.93% or 207.40 points) to close at 22,544.70, successfully reversing previous losses. Sensex followed suit, gaining 0.83% or 609.86 points to settle at 74,340.09, driven by broad-based buying.

by: GOBankingRates

What to Do with Money Sitting in the Bank: Top Options for 2025

Maximizing your money involves choosing high-yield savings options, investing wisely, and using funds strategically for financial growth and stability.

by: Mint

India's oldest index fund completes 25 years

Since its launch in 2000, it has delivered a return of 11.51%, which means a sum of ₹10 lakh invested at its launch would have grown to approximately ₹1.5 crore today.

by: GOBankingRates

How Rich You'd Be If You Invested $1,000 in These 5 Major Companies 10 Years Ago

Whether you are formulating a short-term or long-term investment strategy, the thing to remember is that while catching lightning in a bottle with a skyrocketing stock is great, overall,

by: Barchart

How Is Gilead Sciences' Stock Performance Compared to Other Pharmaceutical Stocks?

Valued at a market cap of $143.8 billion, Gilead Sciences, Inc. (GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in the areas of unmet medical need. The Foster City,

by: MarketWatch

Stock market faces a critical day with Friday's high-stakes jobs report and a Powell speech

Investors should brace for a high-stakes day for the markets Friday, with a critical update on the employment front and a midday speech from Federal Reserve Chair Jerome Powell on deck.

by: WOPRAI

Short squeeze is starting in shares of OTCM at $50, after crossing above the $49.944 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ICLK at $7.95, after crossing above the $7.842 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of AC at $37, after crossing above the $36.669 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of KMDA at $7.43, after crossing above the $7.369 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of FNWD at $27.9, after crossing above the $27.71 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ANCTF at $51.62, after crossing above the $50.822 Trigger Price

  • Fri, March 7, 2025

by: MSN

Building a Real Estate Portfolio: Strategies for Millennial CEOs

Unlike stocks or bonds, which are susceptible to volatility, real estate is a smarter choice because it appreciates over time and offers more stability. More millennial CEOs are tilting towards investing in real estate and building a rich real estate portfolio.

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Cutera, Inc. in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Wearable Devices Ltd. in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Arvana Inc. in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Freight Technologies, Inc. in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of ATI Physical Therapy, Inc. in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Spirits Time International, Inc. in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Alpha Tau Medical Ltd. in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Azure Holding Group Corp. in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Aclarion, Inc. in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Eos Energy Enterprises, Inc. in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Sleep Number Corporation in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Botanix Pharmaceuticals Limited in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Cyclo Therapeutics, Inc. in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of TOHO TITANIUM in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of CareCloud, Inc. in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Creative Medical Technology Holdings, Inc. in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of CHORD ENERGY CORPORATION in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Alpha Technology Group Limited in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Ayr Wellness Inc. in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Vicinity Centres in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of Green Planet Bioengineering Co Ltd in recent trading

by: WOPRAI

As of Mar 07th, 2025, there has been substantial selling of in recent trading

by: WOPRAI

75 Earnings Releases for Mar 07th, 2025

How Is Gilead Sciences' Stock Performance Compared to Other Pharmaceutical Stocks?

Valued at a market cap of $143.8 billion, Gilead Sciences, Inc. (GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in the areas of unmet medical need. The Foster City,
Gilead Sciences, Inc. has shown a year-to-date increase of about 10.1% in its stock value, which is slightly below the average performance of other stocks in the Medical - Biomedical and Genetics industry, which have risen by approximately 10.5%. Over the past six months, Gilead's stock has risen by 1.3%, while the industry average was a 1.6% increase. This indicates that Gilead is performing comparably but not outperforming its peers. The article also discusses broader market trends, noting that the S&P 500 has gained about 17.6% year-to-date, highlighting that the pharmaceutical sector, including Gilead, has not kept pace with the general market's growth. Additionally, the article provides insights into Gilead's financial health, mentioning its revenue growth and profitability metrics, which are crucial for investors considering the stock's future potential.

Read the Full Barchart Article at:
https://www.msn.com/en-us/money/savingandinvesting/how-is-gilead-sciences-stock-performance-compared-to-other-pharmaceutical-stocks/ar-AA1AnJd3